Soleno Therapeutics's total assets for Q4 2024 were $330.97M, an increase of 11.55% from the previous quarter. SLNO total liabilities were $85.86M for the fiscal quarter, a 168.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.